Concepts (273)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Staphylococcus aureus | 50 | 2024 | 1461 | 6.540 |
Why?
|
| Staphylococcal Infections | 34 | 2024 | 1412 | 4.470 |
Why?
|
| Bacterial Capsules | 19 | 2019 | 246 | 3.440 |
Why?
|
| Staphylococcal Vaccines | 11 | 2021 | 30 | 3.340 |
Why?
|
| Polysaccharides, Bacterial | 14 | 2019 | 582 | 2.220 |
Why?
|
| Virulence Factors | 5 | 2024 | 512 | 1.390 |
Why?
|
| Antibodies, Bacterial | 10 | 2021 | 1480 | 1.060 |
Why?
|
| Bacterial Proteins | 18 | 2024 | 3861 | 0.980 |
Why?
|
| Bacterial Toxins | 4 | 2021 | 926 | 0.960 |
Why?
|
| Coagulase | 3 | 2016 | 53 | 0.900 |
Why?
|
| Staphylococcal Skin Infections | 6 | 2021 | 78 | 0.860 |
Why?
|
| Antigens, Bacterial | 6 | 2016 | 1150 | 0.700 |
Why?
|
| Cytotoxins | 1 | 2018 | 154 | 0.570 |
Why?
|
| Bacterial Vaccines | 3 | 2016 | 400 | 0.570 |
Why?
|
| Hemolysin Proteins | 1 | 2016 | 113 | 0.540 |
Why?
|
| Bacteremia | 7 | 2017 | 985 | 0.540 |
Why?
|
| Cell Wall | 4 | 2018 | 420 | 0.530 |
Why?
|
| Abscess | 5 | 2016 | 607 | 0.510 |
Why?
|
| Immunization, Passive | 5 | 2016 | 621 | 0.500 |
Why?
|
| Soft Tissue Infections | 1 | 2016 | 168 | 0.470 |
Why?
|
| Teichoic Acids | 2 | 2015 | 69 | 0.470 |
Why?
|
| Inflammasomes | 1 | 2020 | 541 | 0.470 |
Why?
|
| Wound Infection | 1 | 2016 | 244 | 0.460 |
Why?
|
| Anti-Bacterial Agents | 11 | 2021 | 7467 | 0.440 |
Why?
|
| Surgical Wound Infection | 3 | 2016 | 1544 | 0.440 |
Why?
|
| Virulence | 8 | 2024 | 1301 | 0.440 |
Why?
|
| Cross Reactions | 1 | 2014 | 825 | 0.410 |
Why?
|
| Neutrophils | 7 | 2021 | 3790 | 0.400 |
Why?
|
| Bacterial Adhesion | 3 | 2015 | 305 | 0.400 |
Why?
|
| Staphylococcus haemolyticus | 2 | 2007 | 6 | 0.370 |
Why?
|
| Polysaccharides | 2 | 2019 | 1024 | 0.370 |
Why?
|
| Methicillin-Resistant Staphylococcus aureus | 4 | 2022 | 704 | 0.360 |
Why?
|
| Staphylococcus | 1 | 2010 | 153 | 0.340 |
Why?
|
| Macrophages | 3 | 2021 | 5797 | 0.340 |
Why?
|
| Fibrinogen | 2 | 2016 | 893 | 0.320 |
Why?
|
| Antibodies, Neutralizing | 2 | 2021 | 2005 | 0.320 |
Why?
|
| Mice | 27 | 2023 | 82051 | 0.320 |
Why?
|
| Chemokines, CXC | 2 | 2008 | 420 | 0.300 |
Why?
|
| CD4-Positive T-Lymphocytes | 4 | 2013 | 4403 | 0.300 |
Why?
|
| Bacterial Load | 3 | 2017 | 154 | 0.290 |
Why?
|
| Animals | 36 | 2024 | 169424 | 0.290 |
Why?
|
| Sepsis | 2 | 2018 | 2602 | 0.270 |
Why?
|
| Gastrointestinal Diseases | 1 | 2015 | 1207 | 0.270 |
Why?
|
| Glycoproteins | 1 | 2013 | 2207 | 0.260 |
Why?
|
| Vaccines, Subunit | 2 | 2016 | 159 | 0.260 |
Why?
|
| Adhesins, Bacterial | 1 | 2006 | 120 | 0.250 |
Why?
|
| N-Acetylmuramoyl-L-alanine Amidase | 2 | 2016 | 48 | 0.250 |
Why?
|
| Opsonin Proteins | 3 | 2016 | 144 | 0.240 |
Why?
|
| Disease Models, Animal | 15 | 2021 | 18390 | 0.240 |
Why?
|
| Diabetes Complications | 1 | 2011 | 1322 | 0.230 |
Why?
|
| Gene Expression Regulation, Bacterial | 6 | 2019 | 1139 | 0.230 |
Why?
|
| Vaccines, Synthetic | 3 | 2016 | 622 | 0.230 |
Why?
|
| Immunoglobulins, Intravenous | 1 | 2008 | 672 | 0.220 |
Why?
|
| Phagocytosis | 3 | 2016 | 1531 | 0.220 |
Why?
|
| Membrane Proteins | 2 | 2023 | 7895 | 0.220 |
Why?
|
| Nasal Mucosa | 1 | 2006 | 412 | 0.210 |
Why?
|
| Diabetes Mellitus, Experimental | 1 | 2008 | 1121 | 0.200 |
Why?
|
| Rabbits | 5 | 2021 | 4786 | 0.200 |
Why?
|
| Skin Diseases | 1 | 2010 | 1099 | 0.190 |
Why?
|
| Host-Pathogen Interactions | 2 | 2021 | 1462 | 0.190 |
Why?
|
| Diabetic Foot | 1 | 2005 | 383 | 0.190 |
Why?
|
| Escherichia coli | 1 | 2013 | 4220 | 0.190 |
Why?
|
| Vaccines, Conjugate | 4 | 2017 | 334 | 0.180 |
Why?
|
| Erythromycin | 1 | 2021 | 115 | 0.180 |
Why?
|
| Blood Bactericidal Activity | 2 | 2014 | 124 | 0.180 |
Why?
|
| Osmotic Pressure | 1 | 2021 | 137 | 0.180 |
Why?
|
| Mice, Inbred ICR | 2 | 2014 | 363 | 0.180 |
Why?
|
| Membrane Fluidity | 1 | 2020 | 67 | 0.170 |
Why?
|
| HL-60 Cells | 1 | 2021 | 364 | 0.170 |
Why?
|
| Mastitis | 3 | 2016 | 43 | 0.170 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 2011 | 4362 | 0.170 |
Why?
|
| Pore Forming Cytotoxic Proteins | 1 | 2020 | 130 | 0.170 |
Why?
|
| Carbohydrate Sequence | 2 | 2010 | 411 | 0.160 |
Why?
|
| Peptidoglycan | 2 | 2018 | 246 | 0.160 |
Why?
|
| Amyloid | 1 | 2023 | 852 | 0.150 |
Why?
|
| Immunity, Innate | 2 | 2016 | 3076 | 0.150 |
Why?
|
| Mice, Inbred BALB C | 5 | 2021 | 6241 | 0.150 |
Why?
|
| Survival Analysis | 4 | 2018 | 10127 | 0.140 |
Why?
|
| Cell Survival | 2 | 2021 | 5800 | 0.140 |
Why?
|
| Blood Platelets | 1 | 2007 | 2485 | 0.130 |
Why?
|
| Adjuvants, Immunologic | 3 | 2017 | 998 | 0.130 |
Why?
|
| Multigene Family | 3 | 2019 | 1081 | 0.130 |
Why?
|
| Cystic Fibrosis | 2 | 2016 | 1287 | 0.130 |
Why?
|
| Pneumonia, Staphylococcal | 2 | 2013 | 39 | 0.130 |
Why?
|
| Sphingomyelin Phosphodiesterase | 1 | 2016 | 83 | 0.130 |
Why?
|
| Microvilli | 1 | 2016 | 235 | 0.130 |
Why?
|
| Endocytosis | 1 | 2020 | 960 | 0.120 |
Why?
|
| Apoptosis | 1 | 2011 | 9526 | 0.120 |
Why?
|
| Lipoproteins | 1 | 2020 | 880 | 0.120 |
Why?
|
| Cross Protection | 1 | 2014 | 25 | 0.120 |
Why?
|
| rhoA GTP-Binding Protein | 1 | 2016 | 237 | 0.120 |
Why?
|
| Drug Compounding | 1 | 2016 | 243 | 0.120 |
Why?
|
| Cell Membrane | 1 | 2024 | 3663 | 0.120 |
Why?
|
| Hydro-Lyases | 1 | 2014 | 94 | 0.120 |
Why?
|
| Biofilms | 3 | 2022 | 634 | 0.110 |
Why?
|
| Temperature | 1 | 2021 | 2237 | 0.110 |
Why?
|
| Mice, Inbred C57BL | 7 | 2016 | 22365 | 0.110 |
Why?
|
| Microbial Sensitivity Tests | 6 | 2021 | 1965 | 0.110 |
Why?
|
| Hindlimb | 2 | 2006 | 516 | 0.110 |
Why?
|
| Biological Therapy | 1 | 2015 | 140 | 0.110 |
Why?
|
| Carrier State | 2 | 2016 | 529 | 0.110 |
Why?
|
| Glycoconjugates | 1 | 2013 | 88 | 0.110 |
Why?
|
| Biosynthetic Pathways | 1 | 2014 | 138 | 0.110 |
Why?
|
| Glycerophosphates | 1 | 2013 | 50 | 0.110 |
Why?
|
| Microbial Viability | 1 | 2014 | 236 | 0.110 |
Why?
|
| Osteomyelitis | 2 | 2016 | 408 | 0.110 |
Why?
|
| Adaptation, Biological | 1 | 2013 | 147 | 0.100 |
Why?
|
| Molecular Sequence Data | 5 | 2010 | 17637 | 0.100 |
Why?
|
| Genetic Engineering | 1 | 2018 | 936 | 0.100 |
Why?
|
| Cells, Cultured | 4 | 2020 | 19035 | 0.100 |
Why?
|
| Leukocidins | 2 | 2008 | 18 | 0.100 |
Why?
|
| Pseudomonas aeruginosa | 2 | 2014 | 1277 | 0.100 |
Why?
|
| Placebos | 1 | 2016 | 1668 | 0.090 |
Why?
|
| Exotoxins | 2 | 2008 | 123 | 0.090 |
Why?
|
| Bacteriophages | 1 | 2015 | 382 | 0.090 |
Why?
|
| Endopeptidases | 1 | 2015 | 772 | 0.090 |
Why?
|
| Microscopy, Confocal | 3 | 2016 | 1977 | 0.090 |
Why?
|
| Drug Evaluation, Preclinical | 1 | 2016 | 1339 | 0.090 |
Why?
|
| Genes, Bacterial | 3 | 2006 | 1076 | 0.090 |
Why?
|
| Vaccination | 2 | 2018 | 3433 | 0.090 |
Why?
|
| Vancomycin | 1 | 2013 | 506 | 0.080 |
Why?
|
| Microscopy, Atomic Force | 1 | 2010 | 252 | 0.080 |
Why?
|
| Oxidative Stress | 1 | 2021 | 3145 | 0.080 |
Why?
|
| Electrolytes | 1 | 2010 | 278 | 0.080 |
Why?
|
| Gentamicins | 1 | 2010 | 245 | 0.080 |
Why?
|
| Proteomics | 1 | 2023 | 3901 | 0.080 |
Why?
|
| Humans | 25 | 2024 | 768369 | 0.080 |
Why?
|
| Magnetic Resonance Spectroscopy | 2 | 2010 | 3783 | 0.080 |
Why?
|
| Epithelial Cells | 1 | 2021 | 3697 | 0.080 |
Why?
|
| Epitopes | 1 | 2014 | 2523 | 0.070 |
Why?
|
| Microscopy, Immunoelectron | 1 | 2007 | 317 | 0.070 |
Why?
|
| Methicillin Resistance | 1 | 2008 | 198 | 0.070 |
Why?
|
| Recombinant Fusion Proteins | 1 | 2016 | 3735 | 0.070 |
Why?
|
| Genetic Complementation Test | 3 | 2015 | 557 | 0.070 |
Why?
|
| Receptors, Leptin | 1 | 2008 | 351 | 0.070 |
Why?
|
| Operon | 2 | 2019 | 372 | 0.070 |
Why?
|
| Immunoglobulin G | 2 | 2016 | 4570 | 0.070 |
Why?
|
| Rats, Wistar | 2 | 2013 | 1891 | 0.070 |
Why?
|
| Membrane Transport Proteins | 1 | 2012 | 1036 | 0.070 |
Why?
|
| Antibodies, Monoclonal | 3 | 2016 | 9261 | 0.070 |
Why?
|
| Cattle | 3 | 2008 | 3830 | 0.070 |
Why?
|
| Microfluidic Analytical Techniques | 1 | 2012 | 825 | 0.070 |
Why?
|
| Genome, Bacterial | 2 | 2015 | 798 | 0.060 |
Why?
|
| Female | 15 | 2021 | 396926 | 0.060 |
Why?
|
| Mice, Mutant Strains | 1 | 2008 | 1755 | 0.060 |
Why?
|
| Vaccines, Inactivated | 1 | 2006 | 185 | 0.060 |
Why?
|
| Promoter Regions, Genetic | 3 | 2019 | 5803 | 0.060 |
Why?
|
| Respiratory Burst | 1 | 2005 | 110 | 0.060 |
Why?
|
| Growth Inhibitors | 1 | 2006 | 375 | 0.060 |
Why?
|
| Serotyping | 1 | 2005 | 332 | 0.060 |
Why?
|
| Intestinal Mucosa | 1 | 2016 | 3047 | 0.060 |
Why?
|
| Rats, Sprague-Dawley | 1 | 2016 | 8201 | 0.060 |
Why?
|
| Diabetes Mellitus, Type 2 | 1 | 2008 | 12242 | 0.060 |
Why?
|
| Keratins | 1 | 2006 | 502 | 0.060 |
Why?
|
| Community-Acquired Infections | 1 | 2008 | 473 | 0.060 |
Why?
|
| Administration, Intranasal | 1 | 2006 | 485 | 0.060 |
Why?
|
| Mammary Glands, Animal | 1 | 2005 | 273 | 0.060 |
Why?
|
| Enzyme Inhibitors | 1 | 2014 | 3734 | 0.050 |
Why?
|
| Family Health | 1 | 2008 | 1256 | 0.050 |
Why?
|
| Molecular Structure | 1 | 2007 | 1889 | 0.050 |
Why?
|
| Uridine Diphosphate Sugars | 1 | 2002 | 10 | 0.050 |
Why?
|
| Complement C3 | 1 | 2005 | 434 | 0.050 |
Why?
|
| Uridine Diphosphate N-Acetylglucosamine | 1 | 2002 | 18 | 0.050 |
Why?
|
| Cell Aggregation | 1 | 2022 | 238 | 0.050 |
Why?
|
| Vitamin K 3 | 1 | 2021 | 14 | 0.050 |
Why?
|
| Base Sequence | 3 | 2012 | 12426 | 0.050 |
Why?
|
| O Antigens | 1 | 2002 | 196 | 0.050 |
Why?
|
| Leukocytes, Mononuclear | 1 | 2008 | 1852 | 0.050 |
Why?
|
| Rats | 4 | 2016 | 23839 | 0.050 |
Why?
|
| Mice, Inbred NOD | 1 | 2005 | 1840 | 0.050 |
Why?
|
| DNA, Bacterial | 1 | 2005 | 1474 | 0.040 |
Why?
|
| Transcription, Genetic | 3 | 2019 | 7602 | 0.040 |
Why?
|
| Point Mutation | 1 | 2006 | 1596 | 0.040 |
Why?
|
| Urea | 1 | 2022 | 447 | 0.040 |
Why?
|
| Antibodies | 1 | 2008 | 2426 | 0.040 |
Why?
|
| Nose | 2 | 2015 | 524 | 0.040 |
Why?
|
| Sequence Analysis, DNA | 2 | 2015 | 4774 | 0.040 |
Why?
|
| Interferon-gamma | 1 | 2008 | 3164 | 0.040 |
Why?
|
| Disease Outbreaks | 1 | 2008 | 1763 | 0.040 |
Why?
|
| Disease Susceptibility | 1 | 2005 | 1796 | 0.040 |
Why?
|
| RNA, Bacterial | 2 | 2015 | 393 | 0.040 |
Why?
|
| Sigma Factor | 1 | 2019 | 177 | 0.040 |
Why?
|
| Conserved Sequence | 2 | 2015 | 1163 | 0.040 |
Why?
|
| Phenotype | 1 | 2015 | 16712 | 0.040 |
Why?
|
| Glutamic Acid | 1 | 2022 | 1192 | 0.030 |
Why?
|
| Flow Cytometry | 1 | 2007 | 5893 | 0.030 |
Why?
|
| Hyperglycemia | 1 | 2005 | 1389 | 0.030 |
Why?
|
| Immunization | 1 | 2021 | 1220 | 0.030 |
Why?
|
| Signal Transduction | 1 | 2020 | 23639 | 0.030 |
Why?
|
| Repressor Proteins | 2 | 2019 | 2987 | 0.030 |
Why?
|
| Cell Line | 1 | 2010 | 15610 | 0.030 |
Why?
|
| Complement C3b | 1 | 2016 | 98 | 0.030 |
Why?
|
| Chromosomes, Bacterial | 2 | 2008 | 281 | 0.030 |
Why?
|
| Mutation | 3 | 2016 | 30235 | 0.030 |
Why?
|
| Suramin | 1 | 2014 | 34 | 0.030 |
Why?
|
| Cell Proliferation | 1 | 2010 | 10490 | 0.030 |
Why?
|
| Ceramides | 1 | 2016 | 203 | 0.030 |
Why?
|
| Ampicillin | 1 | 2014 | 137 | 0.030 |
Why?
|
| Quorum Sensing | 1 | 2015 | 137 | 0.030 |
Why?
|
| Cell Movement | 1 | 2006 | 5223 | 0.030 |
Why?
|
| DNA Primers | 2 | 2012 | 2825 | 0.030 |
Why?
|
| Hydrolysis | 1 | 2015 | 654 | 0.030 |
Why?
|
| Alum Compounds | 1 | 2013 | 34 | 0.030 |
Why?
|
| Salmonella typhimurium | 1 | 2016 | 348 | 0.030 |
Why?
|
| Inhibitory Concentration 50 | 1 | 2014 | 467 | 0.030 |
Why?
|
| Molecular Typing | 1 | 2013 | 116 | 0.030 |
Why?
|
| Fungal Proteins | 1 | 1997 | 908 | 0.030 |
Why?
|
| Immune Sera | 1 | 2013 | 605 | 0.030 |
Why?
|
| Tetanus Toxoid | 1 | 2013 | 189 | 0.030 |
Why?
|
| Clinical Trials as Topic | 1 | 2008 | 8051 | 0.030 |
Why?
|
| Trans-Activators | 1 | 2002 | 2858 | 0.020 |
Why?
|
| Immunomodulation | 1 | 2016 | 550 | 0.020 |
Why?
|
| Kinetics | 2 | 2014 | 6347 | 0.020 |
Why?
|
| Oligodeoxyribonucleotides | 1 | 2013 | 706 | 0.020 |
Why?
|
| Male | 8 | 2021 | 364761 | 0.020 |
Why?
|
| Binding Sites | 1 | 2019 | 6029 | 0.020 |
Why?
|
| Culture Media | 1 | 2012 | 899 | 0.020 |
Why?
|
| Static Electricity | 1 | 2010 | 261 | 0.020 |
Why?
|
| Bronchi | 1 | 2013 | 847 | 0.020 |
Why?
|
| Acetylglucosamine | 1 | 2010 | 189 | 0.020 |
Why?
|
| Methicillin | 1 | 2008 | 62 | 0.020 |
Why?
|
| Actins | 1 | 2016 | 2064 | 0.020 |
Why?
|
| Fluorescent Dyes | 1 | 2016 | 1924 | 0.020 |
Why?
|
| Bacterial Infections | 1 | 2016 | 1397 | 0.020 |
Why?
|
| Stress, Mechanical | 1 | 2012 | 1680 | 0.020 |
Why?
|
| Plasmids | 1 | 2012 | 2269 | 0.020 |
Why?
|
| Protein Binding | 1 | 2019 | 9376 | 0.020 |
Why?
|
| Adaptation, Physiological | 1 | 2013 | 1315 | 0.020 |
Why?
|
| Gene Silencing | 1 | 2013 | 1502 | 0.020 |
Why?
|
| Evolution, Molecular | 1 | 2015 | 1894 | 0.020 |
Why?
|
| Synteny | 1 | 2005 | 77 | 0.020 |
Why?
|
| Neutrophil Infiltration | 1 | 2008 | 396 | 0.020 |
Why?
|
| Gene Order | 1 | 2005 | 169 | 0.020 |
Why?
|
| Sequence Homology | 1 | 2005 | 198 | 0.020 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 2012 | 3813 | 0.020 |
Why?
|
| Staphylococcus epidermidis | 1 | 2005 | 123 | 0.020 |
Why?
|
| Recombinant Proteins | 1 | 2015 | 6527 | 0.020 |
Why?
|
| Gene Deletion | 1 | 2012 | 2674 | 0.010 |
Why?
|
| Histocompatibility Antigens Class II | 1 | 2008 | 1438 | 0.010 |
Why?
|
| Up-Regulation | 1 | 2013 | 4132 | 0.010 |
Why?
|
| Iron | 1 | 2012 | 1813 | 0.010 |
Why?
|
| Electrophoresis, Capillary | 1 | 2002 | 63 | 0.010 |
Why?
|
| Genome-Wide Association Study | 1 | 2021 | 12771 | 0.010 |
Why?
|
| DNA Transposable Elements | 1 | 2005 | 762 | 0.010 |
Why?
|
| Cross Infection | 1 | 2010 | 1425 | 0.010 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2008 | 4582 | 0.010 |
Why?
|
| Catalysis | 1 | 2002 | 769 | 0.010 |
Why?
|
| Gene Rearrangement | 1 | 2005 | 1139 | 0.010 |
Why?
|
| Gene Expression | 1 | 2013 | 7605 | 0.010 |
Why?
|
| Nuclear Magnetic Resonance, Biomolecular | 1 | 2002 | 510 | 0.010 |
Why?
|
| Biological Evolution | 1 | 2005 | 1081 | 0.010 |
Why?
|
| Transcription Factors | 1 | 2019 | 12176 | 0.010 |
Why?
|
| Genotype | 1 | 2013 | 13045 | 0.010 |
Why?
|
| Treatment Outcome | 2 | 2016 | 65408 | 0.010 |
Why?
|
| Drug Resistance, Bacterial | 1 | 2005 | 1061 | 0.010 |
Why?
|
| Lymphocyte Activation | 1 | 2008 | 5490 | 0.010 |
Why?
|
| Longitudinal Studies | 1 | 2013 | 14766 | 0.010 |
Why?
|
| Sequence Analysis | 1 | 1997 | 240 | 0.010 |
Why?
|
| Mass Spectrometry | 1 | 2002 | 2204 | 0.010 |
Why?
|
| Lung | 1 | 2013 | 10090 | 0.010 |
Why?
|
| Sequence Alignment | 1 | 1997 | 2184 | 0.010 |
Why?
|
| Mice, Knockout | 1 | 2008 | 14483 | 0.010 |
Why?
|
| Child | 2 | 2013 | 80856 | 0.010 |
Why?
|
| Biological Transport | 1 | 1997 | 2090 | 0.010 |
Why?
|
| Cell Line, Tumor | 1 | 2008 | 17149 | 0.010 |
Why?
|
| Chronic Disease | 1 | 2005 | 9379 | 0.010 |
Why?
|
| RNA, Messenger | 1 | 2002 | 12813 | 0.000 |
Why?
|
| Young Adult | 1 | 2013 | 60038 | 0.000 |
Why?
|
| Adult | 2 | 2013 | 223528 | 0.000 |
Why?
|
| Amino Acid Sequence | 1 | 1997 | 13447 | 0.000 |
Why?
|
| Child, Preschool | 1 | 2008 | 42620 | 0.000 |
Why?
|
| Adolescent | 1 | 2013 | 89163 | 0.000 |
Why?
|
| Retrospective Studies | 1 | 2013 | 81835 | 0.000 |
Why?
|
Concepts
(273)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(14)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_
Physical Neighbors
People whose addresses are nearby this person.
_